Development and validation of an LC-ESI-MS/MS method for the quantitation of hemslecin A in rhesus monkey plasma and its application in pharmacokinetics

被引:5
|
作者
Bai, Min [1 ]
Li, Hong-Liang [2 ]
He, Jian-Chang [3 ]
He, Gong-Hao [3 ]
Feng, En-Fu [3 ]
Liu, Yue-Qiong [3 ]
Shi, Pan-Pan [3 ]
Xu, Gui-Li [3 ]
机构
[1] Han Dan Cent Hosp, Dept Pharm, Handan 056001, Hebei, Peoples R China
[2] Sun Yat Sen Univ, Sch Pharmaceut Sci, Inst Clin Pharmacol, Guangzhou 510006, Guangdong, Peoples R China
[3] Kunming Gen Hosp Chengdu Mil Reg, Dept Pharm, Kunming 650032, Peoples R China
关键词
hemslecin A; LC-ESI-MS; MS; rhesus monkey plasma; pharmacokinetics; CYTOTOXIC CONSTITUENTS; CUCURBITACINS;
D O I
10.1002/bmc.3032
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In this study, a new LC-ESI-MS/MS-based method was validated for the quantitation of hemslecin A in rhesus monkey plasma using otophylloside A as internal standard (IS). Hemslecin A and the IS were extracted from rhesus monkey plasma using liquid-liquid extraction as the sample clean-up procedure, and were subjected to chromatography on a Phenomenex Luna CN column (150x2.0mm, 3.0 mu m) with the mobile phase consisting of methanol and 0.02mol/mL ammonium acetate (55:45, v/v) at a flow rate of 0.2mL/min. Detection was performed on an Agilent G6410B tandem mass spectrometer by positive ion electrospray ionization in multiple reaction monitoring mode, monitoring the transitions m/z 580.5 [M+NH4](+)503.4 and m/z 518.2 [M+NH4](+)345.0 for hemslecin A and IS, respectively. The assay was linear over the concentration range of 0.5-200ng/mL and was successfully applied to a pharmacokinetic study in rhesus monkeys. Copyright (c) 2013 John Wiley & Sons, Ltd.
引用
收藏
页码:385 / 390
页数:6
相关论文
共 50 条
  • [1] Development and validation of a LC-ESI-MS/MS method for the determination of swertiamarin in rat plasma and its application in pharmacokinetics
    Li, Hong-Liang
    Peng, Xiao-Jin
    He, Jian-Chang
    Feng, En-Fu
    Xu, Gui-Li
    Rao, Gao-Xiong
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2011, 879 (19): : 1653 - 1658
  • [2] Development and validation of an LC-ESI-MS/MS method for simultaneous quantitation of olmesartan and pioglitazone in rat plasma and its pharmacokinetic application
    Sengupta, Pinaki
    Sarkar, Amlan Kanti
    Bhaumik, Uttam
    Chatterjee, Bappaditya
    Roy, Bikash
    Chakraborty, Uday Shankar
    Pal, Tapan Kumar
    [J]. BIOMEDICAL CHROMATOGRAPHY, 2010, 24 (12) : 1342 - 1349
  • [3] LC-ESI-MS/MS Method for the Fosamprenavir Quantification Bioanalytical Method Development and Validation for the Quantification Fosamprenavir in Human Plasma by LC-ESI-MS/MS
    Susmitha, Kondam
    Menaka, Muthukkarupan
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2022, 56 (03) : S599 - S604
  • [4] METHOD DEVELOPMENT AND VALIDATION OF LC-ESI-MS/MS TECHNIQUE FOR THE ESTIMATION OF MODAFINIL IN HUMAN PLASMA; APPLICATION TO PHARMACOKINETICS IN HEALTHY RABBITS
    Phanindra, Adluri
    Kumar, Y. Shravan
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (04): : 1837 - 1844
  • [5] Development and Validation of LC-ESI-MS/MS Method for the Determination of Alfuzosin in Human Plasma
    Rania M. Moustapha E. Moustapha
    Mehnaz El Gamal
    [J]. Journal of Analytical Chemistry, 2021, 76 : 1327 - 1335
  • [6] Development and Validation of LC-ESI-MS/MS Method for the Determination of Alfuzosin in Human Plasma
    Moustapha, Moustapha E.
    El Gamal, Rania M.
    Kamal, Mehnaz
    [J]. JOURNAL OF ANALYTICAL CHEMISTRY, 2021, 76 (11) : 1327 - 1335
  • [7] Development and validation of a rapid LC-ESI-MS/MS method for quantification of fluoxetine and its application to MS binding assays
    Marielle Hess
    Georg Höfner
    Klaus Theodor Wanner
    [J]. Analytical and Bioanalytical Chemistry, 2011, 400 : 3505 - 3515
  • [8] Development and validation of a rapid LC-ESI-MS/MS method for quantification of fluoxetine and its application to MS binding assays
    Hess, Marielle
    Hoefner, Georg
    Wanner, Klaus Theodor
    [J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2011, 400 (10) : 3505 - 3515
  • [9] A Sensitive Bioanalytical Method Development And Validation Of Pazopanib In Human Plasma By LC-ESI-MS/MS
    Annapurna, M.
    Shanthi, Priya D. K.
    [J]. JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 : 855 - 861
  • [10] A sensitive bioanalytical method development and validation of cabozantinib in human plasma by LC-ESI-MS/MS
    Inturi, Srikanth
    Avula, Prameela Rani
    [J]. BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 54 (02)